The Good, The Bad, and The Ugly in Medtech Deals

Some deals work and some deals don’t. A look at the good, bad and ugly deals in recent medtech history.

Omar Ford

February 23, 2024

9 Slides

Already have an account?

Image Credit: istocksdaily/Getty Images

There have been some truly exceptional deals that have shaped the medtech landscape. Some of these acquisitions have had a positive impact – and others … well, not so much.

MD+DI has rated the good, the bad, and the ugly of medtech deals.

And you can check out MD+DI’s annual Top Deals List here.

About the Author

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like